Pharmafile Logo
Pharmafocus logo
Advanced Search
teva_copy

Teva hit with record fine $519 million corruption fine

December 23, 2016
Medical Communications Teva, corruption, fine

Teva Pharmaceuticals, the world’s largest generics company, has been hit with the largest criminal fine to come from the US …

News
business

2016 Top markets report

December 23, 2016
Medical Communications market, market access

2016 Top Markets Report

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this year

December 23, 2016
Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

As we’re now in the New Year, here at Pharmafocus, we thought we would do a recap of the ten …

News
merrimack-pharmaceuticals

Merrimack’s breast cancer trial stutters to halt

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merrimack Pharmaceuticals, merrimack

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …

News
frederik_wilkinson

Impax Laboratories parts with CEO

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Impax Laboratories

Impax Laboratories announced on 20 December that CEO Frederik Wilkinson has left his position of president and CEO, as well …

Appointment
2017

Seven pharma trends for 2017

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …

Feature
novonordiskhq

Fluor wins $2 billion Novo contract to build API manufacturing facility

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fluor, Novo Nordisk, north carolina

Fluor Corporation has won an engineering, procurement and construction management contract for Novo Nordisk’s $2 billion diabetes active pharmaceutical ingredient …

News
jj_2johnson_and_johnson

Actelion acquisition hokey-cokey continues with J&J returning to table

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …

News
sun_pharma

Sun Pharma to acquire Novartis’s drug for $175 million

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sun Pharma

Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …

News
roche__tree

Roche’s ground-breaking MS drug delayed by manufacturing issues

December 22, 2016
Genentech, MS, Roche, multiple sclerosis

Roche has released both good and bad news just before Christmas. The good news is very good news for individuals …

News
novartis_hq_day

Colombian government forces through near half-price cut of Novartis drug

December 21, 2016
Medical Communications, Sales and Marketing Colombia, Novartis

The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …

News
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

New research reverses HIV-related immune suppression

December 21, 2016
Research and Development HIV, UNC School of Medicine

The UNC School of Medicine has released new research which appears to offer a new approach to HIV treatment which …

News
fdaoutsideweb

FDA new drug approvals sink to six year low

December 21, 2016
Medical Communications, Research and Development FDA, NDA, new drug approvals

The FDA has released figures to show that drug approvals have fallen from last year’s high of 45 new drugs …

News
allergan

Allergan shells out $2.9bn for regenerative medicine unit LifeCell

December 21, 2016
Research and Development, Sales and Marketing Allergan, LifeCell, acquisition

Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …

News

Novartis seals two deals to bolster drug pipeline

December 21, 2016
Research and Development Conatus, Encore Vision, Novartis

Novartis has consolidated its ophthalmology position by acquiring Encore Vision, a Fort Worth-based US company. The company is focused on …

News
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

Appointment
640px-prostatic_adenocarcinoma_with_perineural_invasion

Treatment using light and deep-sea bacteria kills cancer cells

December 20, 2016
Medical Communications, Research and Development Vascular-targeted photodynamic therapy

A technique called vascular-targeted photodynamic therapy (VTP) has been developed that sent 49% of patients suffering from prostate cancer into …

News

Japan announces measure to crack down on drug pricing

December 20, 2016
Manufacturing and Production, Medical Communications Japan, Shinzo Abe, opdivo

Japan has committed to annual drug price reviews whilst also expanding the scope by which the prices are deemed to …

News

J&J’s largest India site to finally operate by 2018

December 20, 2016
Manufacturing and Production India, Johnson & Johnson

Johnson & Johnson has reportedly announced that its manufacturing plant in Telangana, India, its largest site in the country, is …

News

AstraZeneca opens £120 million UK manufacturing facility

December 20, 2016
Manufacturing and Production AstraZeneca, Macclesfield

AstraZeneca has officially opened a new manufacturing facility for cancer medicines based in Macclesfield, UK. It becomes the second largest …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026